242 related articles for article (PubMed ID: 18627337)
21. Clobetasol propionate spray 0.05% add-on therapy to a stable regimen of biologic treatment in patients with moderate to very severe plaque psoriasis.
Feldman SR; Koo JY; Johnson LA; Preston NJ
Cutis; 2009 Oct; 84(4 Suppl):25-32. PubMed ID: 19916299
[TBL] [Abstract][Full Text] [Related]
22. The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis.
Housman TS; Keil KA; Mellen BG; McCarty MA; Fleischer AB; Feldman SR
J Am Acad Dermatol; 2003 Jul; 49(1):79-82. PubMed ID: 12833013
[TBL] [Abstract][Full Text] [Related]
23. Bioavailability of clobetasol propionate in different vehicles.
Franz TJ; Lehman PA; Feldman SR; Spellman MC
Skin Pharmacol Appl Skin Physiol; 2003; 16(4):212-6. PubMed ID: 12784060
[TBL] [Abstract][Full Text] [Related]
24. A multi-center, open-label study to evaluate the safety and efficacy of a sequential treatment regimen of clobetasol propionate 0.05% spray followed by Calcitriol 3 mg/g ointment in the management of plaque psoriasis.
Brodell RT; Bruce S; Hudson CP; Weiss JS; Colón LE; Johnson LA; Gottschalk RW
J Drugs Dermatol; 2011 Feb; 10(2):158-64. PubMed ID: 21283920
[TBL] [Abstract][Full Text] [Related]
25. Clobetasol-17 propionate lotion under hydrocolloid dressing (Duoderm ET) once weekly versus unoccluded clobetasol-17-propionate ointment twice daily in psoriasis: an immunohistochemical study on remission and relapse.
van der Vleuten CJ; van Vlijmen-Willems IM; de Jong EM; van de Kerkhof PC
Arch Dermatol Res; 1999; 291(7-8):390-5. PubMed ID: 10482007
[TBL] [Abstract][Full Text] [Related]
26. Treatment of scalp psoriasis with clobetasol-17 propionate 0.05% shampoo: a study on daily clinical practice.
Bovenschen HJ; Van de Kerkhof PC
J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):439-44. PubMed ID: 19845822
[TBL] [Abstract][Full Text] [Related]
27. Halobetasol propionate cream by day and halobetasol propionate ointment at night for the treatment of pediatric patients with chronic, localized plaque psoriasis and atopic dermatitis.
Herz G; Blum G; Yawalkar S
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1166-9. PubMed ID: 1757611
[TBL] [Abstract][Full Text] [Related]
28. Treatment of mild-to-moderate chronic hand dermatitis with clobetasol propionate 0.05% EF foam: results from an open-label study.
Kircik LH; Tropmann C
J Drugs Dermatol; 2011 Dec; 10(12):1398-402. PubMed ID: 22134563
[TBL] [Abstract][Full Text] [Related]
29. Medication formulation affects quality of life: a randomized single-blind study of clobetasol propionate foam 0.05% compared with a combined program of clobetasol cream 0.05% and solution 0.05% for the treatment of psoriasis.
Bergstrom KG; Arambula K; Kimball AB
Cutis; 2003 Nov; 72(5):407-11. PubMed ID: 14655784
[TBL] [Abstract][Full Text] [Related]
30. Clobetasol propionate foam in the treatment of psoriasis.
Reid DC; Kimball AB
Expert Opin Pharmacother; 2005 Aug; 6(10):1735-40. PubMed ID: 16086659
[TBL] [Abstract][Full Text] [Related]
31. Clobetasol propionate 0.05% lotion in the treatment of moderate to severe atopic dermatitis: a randomized evaluation versus clobetasol propionate emollient cream.
Breneman D; Fleischer AB; Kaplan D; Lebwohl M; Miller B; Pariser D; Rist T; Swinyer L; Liu Y; Foley V
J Drugs Dermatol; 2005; 4(3):330-6. PubMed ID: 15898289
[TBL] [Abstract][Full Text] [Related]
32. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
[TBL] [Abstract][Full Text] [Related]
33. Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of scalp psoriasis.
Poulin Y; Papp K; Bissonnette R; Guenther L; Tan J; Lynde C; Kerrouche N; Villemagne H;
Cutis; 2010 Jan; 85(1):43-50. PubMed ID: 20184211
[TBL] [Abstract][Full Text] [Related]
34. Juvenile pustular psoriasis associated with steroid withdrawal syndrome due to topical corticosteroid.
Saeki H; Watanabe A; Tada Y; Kakinuma T; Komine M; Ihn H; Asahina A; Etoh T; Kitanaka S; Sato U; Kano H; Igarashi T; Tamaki K
J Dermatol; 2008 Sep; 35(9):601-3. PubMed ID: 18837708
[No Abstract] [Full Text] [Related]
35. Safety and Efficacy of Clobetasol Propionate 0.05% Emollient Foam for the Treatment of Central Centrifugal Cicatricial Alopecia.
Callender VD; Kazemi A; Young CM; Chappell JA; Sperling LC
J Drugs Dermatol; 2020 Jul; 19(7):719-724. PubMed ID: 32726554
[TBL] [Abstract][Full Text] [Related]
36. A new delivery system of clobetasol-17-propionate (lipid-loaded microspheres 0.025%) compared with a conventional formulation (lipophilic ointment in a hydrophilic phase 0.025%) in topical treatment of atrophic/erosive oral lichen planus. A Phase IV, randomized, observer-blinded, parallel group clinical trial.
Campisi G; Giandalia G; De Caro V; Di Liberto C; Aricò P; Giannola LI
Br J Dermatol; 2004 May; 150(5):984-90. PubMed ID: 15149513
[TBL] [Abstract][Full Text] [Related]
37. Different treatment outcomes with different formulations of clobetasol propionate 0.05% for the treatment of plaque psoriasis.
Mraz S; Leonardi C; Colón LE; Johnson LA
J Dermatolog Treat; 2008; 19(6):354-9. PubMed ID: 18923991
[TBL] [Abstract][Full Text] [Related]
38. Molecular signatures order the potency of topically applied anti-inflammatory drugs in patients with atopic dermatitis.
Guttman-Yassky E; Ungar B; Malik K; Dickstein D; Suprun M; Estrada YD; Xu H; Peng X; Oliva M; Todd D; Labuda T; Suarez-Farinas M; Bissonnette R
J Allergy Clin Immunol; 2017 Oct; 140(4):1032-1042.e13. PubMed ID: 28238742
[TBL] [Abstract][Full Text] [Related]
39. Clobetasol propionate lotion in the treatment of moderate to severe plaque-type psoriasis.
Decroix J; Pres H; Tsankov N; Poncet M; Arsonnaud S
Cutis; 2004 Sep; 74(3):201-6. PubMed ID: 15499763
[TBL] [Abstract][Full Text] [Related]
40. Increasing use of non-traditional vehicles for psoriasis and other inflammatory skin conditions.
Huang KE; Davis SA; Cantrell J; Feldman SR
Dermatol Online J; 2014 Sep; 20(9):. PubMed ID: 25244174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]